Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corbus Pharmaceuticals Holdings (CRBP) Net Cash Flow (2016 - 2025)

Corbus Pharmaceuticals Holdings has reported Net Cash Flow over the past 9 years, most recently at $2.5 million for Q4 2023.

  • For Q4 2023, Net Cash Flow fell 45.71% year-over-year to $2.5 million; the TTM value through Dec 2023 reached -$3.3 million, up 59.03%, while the annual FY2024 figure was $3.5 million, 205.95% up from the prior year.
  • Net Cash Flow for Q4 2023 was $2.5 million at Corbus Pharmaceuticals Holdings, down from $2.9 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $48.2 million in Q1 2019 and troughed at -$31.3 million in Q2 2022.
  • A 5-year average of -$1.4 million and a median of $1.0 million in 2021 define the central range for Net Cash Flow.
  • Biggest five-year swings in Net Cash Flow: skyrocketed 483.25% in 2019 and later tumbled 1383.47% in 2022.
  • Year by year, Net Cash Flow stood at -$23.1 million in 2019, then surged by 115.42% to $3.6 million in 2020, then crashed by 439.96% to -$12.1 million in 2021, then skyrocketed by 137.64% to $4.6 million in 2022, then tumbled by 45.71% to $2.5 million in 2023.
  • Business Quant data shows Net Cash Flow for CRBP at $2.5 million in Q4 2023, $2.9 million in Q3 2023, and $1.0 million in Q2 2023.